Mostaghim, A., Minkove, S., Aguilar Company, J., Ruiz, I. (. C., Eremiev-Eremiev, S., Dettorre, G. M., . . . group, O. s. (2024). Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry.
Citación estilo ChicagoMostaghim, Anahita, et al. Previous Immune Checkpoint Inhibitor Therapy Is Associated With Decreased COVID-19-related Hospitalizations and Complications in Patients With Cancer: Results of a Propensity-matched Analysis of the OnCovid Registry. 2024.
Cita MLAMostaghim, Anahita, et al. Previous Immune Checkpoint Inhibitor Therapy Is Associated With Decreased COVID-19-related Hospitalizations and Complications in Patients With Cancer: Results of a Propensity-matched Analysis of the OnCovid Registry. 2024.